SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Midnight is a privacy-first blockchain that blends public verifiability with confidential data handling. You can use Midnight's selective disclosure and ZK proofs to build apps.

Midnight

Discussion centers on Midnights mainnet launch and reported Coinbase listing, with traders also highlighting Google Cloud and Vodafone validator participation as signs of growing reach. Supporters see adoption momentum, while skeptics point to ongoing token-selling pressure and question whether the developments will translate into sustained demand.

T-Mobile US, Inc. engages in the provision of wireless communications services under the T-Mobile and MetroPCS brands. It offers postpaid and prepaid wireless voice, messaging and data services, and wholesale wireless services. The company was founded in 1994 and is headquartered in Bellevue, WA.

T-Mobile US Inc

SpaceXs spectrum acquisition and Starlink Mobile plans to become a wireless carrier have fueled concern that T-Mobile could face greater long-term competition, contributing to a sharp selloff in telecom stocks. Traders are divided between viewing SpaceX as a future threat and calling the reaction excessive because building a competitive terrestrial network would require substantial investment and time.

Bitcoin Cash is a hard fork of Bitcoin with a protocol upgrade to fix on-chain capacity. Bitcoin Cash intends to be a Bitcoin without Segregated Witness (SegWit) as soft fork, where upgrades of the protocol are done mainly through hard forks and without changing the original economic rules of the Bitcoin.  Bitcoin Cash (BCH) is released on 1st August 2017 as an upgraded version of the original Bitcoin Core software. The main upgrade is the increase in the block size limit from 1MB to 8MB. This effectively allows miners on the BCH chain to process up to 8 times more payments per second in comparison to Bitcoin. This makes for faster, cheaper transactions and a much smoother user experience.  Why was Bitcoin Cash Created?  The main objective of Bitcoin Cash is to to bring back the essential qualities of money inherent in the original Bitcoin software. Over the years, these qualities were filtered out of Bitcoin Core and progress was stifled by various people, organizations, and companies involved in Bitcoin protocol development. The result is that Bitcoin Core is currently unusable as money due to increasingly high fees per transactions and transfer times taking hours to complete. This is all because of the 1MB limitation of Bitcoin Core’s block size, causing it unable to accommodate to large number of transactions.  Essentially Bitcoin Cash is a community-activated upgrade (otherwise known as a hard fork) of Bitcoin that increased the block size to 8MB, solving the scaling issues that plague Bitcoin Core today.  Nov 16th 2018: A hashwar resulted in a split between Bitcoin SV and Bitcoin ABC

Bitcoin Cash

Bitcoin Cashs sharp rallies and pullbacks are driving the discussion, with traders citing CME futures access and a Grayscale filing as possible catalysts for an earlier breakout. Bulls point to BCHs relative strength and the planned CashVM upgrade, while skeptics question its utility and warn that momentum could fade.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

IBRXs high-volume rally is being linked to anticipation of founder Patrick Soon-Shiongs Piper Sandler oncology symposium chat, where he is expected to discuss trial progress; traders are also watching for updates on bladder-cancer programs and international expansion. Some bullish posts speculate about a partnership or short squeeze, but those claims remain unverified.

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

IOVAs rally is drawing attention amid the companys higher revenue outlook and expectations for upcoming melanoma, sarcoma and lung-cancer updates. Traders also point to a reported decline in short interest as a possible source of buying pressure, while others warn that the sharp run-up could give way to volatility and debate whether the NSCLC update will arrive on schedule.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

JASMY is drawing attention amid weak price performance and concerns about exchange delistings, with traders debating whether the listing changes are materially bearish or being overstated. Bulls point to JasmyChain activity and ecosystem developments as potential sources of utility, while critics question whether meaningful adoption has emerged.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorillas non-binding plan to acquire its first U.S. data center and expand its AI infrastructure footprint is drawing attention. Some traders view the move as strategic growth, while many question how it will be financed and whether the company can execute, with those concerns accompanying the selloff.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Modernas rally is being linked to its Nasdaq-100 reentry and resulting index-fund buying, as well as optimism around the NIHs planned cancer-vaccine initiative and the companys personalized cancer-vaccine program with Merck. Bulls see potential in the oncology pipeline, while skeptics question the valuation and profitability and attribute part of the move to index flows or short covering.

Aerodrome Finance is a next-generation AMM designed to serve as Base's central liquidity hub, combining a powerful liquidity incentive engine, vote-lock governance model, and friendly user experience. Aerodrome inherits the latest features from Velodrome V2.

Aerodrome Finance

Traders are focused on the planned AerodromeVelodrome merger and expansion of the unified Aero protocol beyond Base to Ethereum and other chains, which they see as a potential source of broader liquidity and fee growth. Sentiment is largely bullish around a breakout toward the $1 level, though some question the rollout timing and warn that emissions or sell-the-news activity could weigh on the token.

Transocean Ltd. engages in the provision of offshore contract drilling services for oil and gas wells. It also owns and operates offshore drilling fleets such as ultra-deepwater, harsh environment, deepwater, and midwater rigs. The company was founded in 1953 and is headquartered in Steinhausen, Switzerland.

Transocean Ltd

The DOJs clearance of Transoceans planned all-stock Valaris merger is a key focus, alongside new contract awards that add to backlog. Traders see potential synergies and elevated short interest as bullish, while others are frustrated by the muted share response and cite debt, dilution, and continued selling pressure.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Ormat Technologies Reports Q2 2026 Results: Full Earnings Call Transcript

Ormat Technologies (NYSE:ORA) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below.
This content is powered by Benzinga APIs.read more...

Implied Volatility Surging for Ormat Technologies Stock Options

Investors need to pay close attention to ORA stock based on the movements in the options market lately. 

This ExxonMobil Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday

Analysts downgraded Liquidia, Sigma Lithium, ExxonMobil, Ormat Technologies and Ethos Technologies, with updated or reduced price targets.read more...

Fervo Hits First Power as Cape Station Geothermal Build Scales

Fervo Energy's Cape Station now has operating megawatts on the grid, with about 900 MW contracted and a much larger buildout still ahead.

FRVO Stock Slides 16.4% in a Week: Is This an Opportunity?

Cape Station's First Power and $11.9 billion in contracted revenue bolster Fervo Energy's growth story, while heavy spending and financing needs remain key risks.

FRVO Stock Hits Its Lowest Valuation: Is It Time to Buy?

Fervo Energy's $11.9 billion in contracted revenue and $2.1 billion cash cushion meet a capital-heavy buildout as geothermal projects move toward operation.

NGG vs. ORA: Which Stock Is the Better Value Option?

NGG or ORA: Which Is the Better Value Stock Right Now?

Why Is Ormat Technologies (ORA) Down 3% Since Last Earnings Report?

Ormat Technologies (ORA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Ormat Technologies, Inc. engages in the geothermal and recovered energy power businesses. It operates through the following segments: Electricity, Product, and Energy Storage. The Electricity segment focuses on the sale of electricity from the company's power plants pursuant to power purchase agreements. The Product segment involves the manufacture, including design and development, of turbines and power units for the supply of electrical energy and in the associated construction of power plants utilizing the power units manufactured by the company to supply energy from geothermal fields and other alternative energy sources. The Energy Storage segment consists of battery energy storage systems as a service and management of curtailable customer loads under contracts with U.S. retail energy providers and directly with large commercial and industrial customers. The company was founded in 1965 and is headquartered in Reno, NV.

Ormat Technologies Inc

Bearish Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Stocktwits

Stocktwits Polls

$ORA It is a good, long established company, but the growth it has shown over the past year does not align with its P/E ratio Its high P/E ratio should be between 27 and 33, not 45.

maynard james keenan

Ormat Technologies shares fell in morning trading after UBS downgraded the geothermal energy company to Neutral from Buy and cut its price target to $100 from $157, citing limited earnings upside through 2028 and valuation multiples that have converged with industry peers. UBS analyst Jon Windham said the firm sees limited upside to earnings through 2028E and limited earnings upside risk through 2029E. 
The downgrade followed Ormat’s Sept. 8 investor day, where management lowered its 2028 adjusted EBITDA run-rate outlook by 3%. UBS also cut its estimated four-year revenue CAGR for Ormat’s energy storage segment to 24% from 32% for 2026-2030 and now expects adjusted EBITDA growth to slow to 9% in 2027 from 13% in 2026. Jefferies maintains a $117 price target with a Hold rating, while Oppenheimer and RBC remain more bullish. 
$ORA

Top Stock Alerts

$ORA as i said...complete reversal of rallys is not good signal. Last 2 reports gains totaly wiped out.

Feed

News

Sentiment

Earnings

Fundamentals

Info

ORA Ormat Technologies Inc

Fundamentals

Latest ORA News